ウェルネス・コミュニケーションズ is acquiring shares in ティーペック jointly with an AIG group company and moving to make it an equity-method affiliate. It will also acquire and absorb through a merger エス・エム・エス's stress-check business, advancing the development of a platform strategy centered on Growbase. The cases cited will be closely watched for further developments.
At a board meeting held on 27 October 2026, ウェルネス・コミュニケーションズ resolved to acquire 32.86% of the issued shares of ティーペック and make it an equity-method affiliate. The acquisition will be carried out jointly with AIG Japan Holdings, American Home Assurance Company, and BellSystem24 Holdings, with the three companies holding more than half of the voting rights in aggregate. The share acquisition is scheduled to be completed on 30 November, although the acquisition price has not been disclosed.
Established in 1989, ティーペック provides telephone health consultations, as well as EAP services, mental health counseling, and medical institution referrals. For the fiscal year ended August 2026, it reported revenue of ¥4,802 million, operating profit of ¥169 million, and net income of ¥134 million. The companies are moving to establish an integrated system centered on Growbase that covers the process from identifying health issues through consultation, support, and resolution. Cross-selling using the three companies' customer bases is also expected.
On the same day, ウェルネス・コミュニケーションズ resolved to acquire all shares of a stress-check business to be established by エス・エム・エス through a company split, and to absorb the company through a merger with ウェルネス・コミュニケーションズ as the surviving company. The share acquisition is scheduled for 1 December, and the merger is scheduled to take effect on 1 January 2027. The business provides stress-check services for medical institutions and nursing-care operators and generated revenue of ¥179 million in the fiscal year ended March 2026. The merger will bring in the customer base, expertise, and personnel, expanding sales of Growbase Mentally and strengthening its rollout to medical institutions.